ARR3tk-eGFP/SV40-mCherry Citations (3)
Originally described in: GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance.Lee E, Wongvipat J, Choi D, Wang P, Lee YS, Zheng D, Watson PA, Gopalan A, Sawyers CL Elife. 2019 Jan 15;8. pii: 41913. doi: 10.7554/eLife.41913. PubMed Journal
Articles Citing ARR3tk-eGFP/SV40-mCherry
| Articles |
|---|
A cell death assay in barley and wheat protoplasts for identification and validation of matching pathogen AVR effector and plant NLR immune receptors.
Saur IML, Bauer S, Lu X, Schulze-Lefert P.
Plant Methods. 2019 Oct 24;15:118. doi: 10.1186/s13007-019-0502-0. eCollection 2019.
PubMed
Associated Plasmids |
| Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Tsoi H, Shi L, Leung MH, Man EPS, So ZQ, Chan WL, Khoo US. Life (Basel). 2022 Jan 10;12(1). pii: life12010093. doi: 10.3390/life12010093. PubMed |
| ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer. Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S, Freedland SJ, Posadas EM, Ellis L, Vizio DD, Morrissey C, Nelson PS, Brady L, Murali R, Campbell MJ, Yang W, Knudsen BS, Mostaghel EA, Ye H, Garraway IP, You S, Freeman MR. bioRxiv [Preprint]. 2023 Oct 12:2023.09.28.560025. doi: 10.1101/2023.09.28.560025. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.